Liquid Watson Reid† 316FUK2001 (Vaccine strain) Obtained as a lyo

Liquid Watson Reid† 316FUK2001 (Vaccine strain) Obtained as a lyophilised stock from the VLA in 2001 and maintained at the Moredun Research Institute, Scotland, UK. 7H11** 316FNLD2008 (Vaccine strain) Obtained from VLA in 2008 and maintained

at the Central Veterinary Institute, Lelystad, SB273005 price Netherlands HEYM IIUK2000 (Vaccine strain) Obtained from the VLA in 2000 and maintained at St George’s Hospital Medical School, London, UK. Liquid Watson Reid†[14] IIUK2001 (Vaccine strain) Obtained as a lyophilised stock from the VLA in 2001 and maintained at the Moredun Research Institute, Scotland, UK. 7H11** 2eUK2000 (Vaccine strain) Obtained from the VLA in 2000 and maintained at St George’s Hospital Medical School, London, UK. Liquid Watson Reid ‘A’ Block†† medium 2eUK2001 (Vaccine strain) Obtained as a lyophilised stock from the VLA in

2001 and maintained at the Moredun Research Institute, Scotland, UK. 7H11** MAPK10 (Wild type strain) Purchased from ATCC: BAA-968. Sequenced reference strain isolated from a cow in 1990. 7H9* or 7H11** CAM87 (Wild type strain) MAP Type III strain isolated from a goat in 2005 [26] and maintained at the Universidad Complutense de Madrid, Madrid, Spain. 7H9* JD87/107 (Wild type strain) Isolated from a deer in 1987 and maintained at the Moredun Research Institute, Scotland, UK. 7H11** *7H9: Middlebrooks 7H9 (Becton Dickinson, UK) supplemented with 2 mg/L Mycobactin J (Allied Monitor,

USA), 0.5% glycerol, 10% oleic acid-albumin-dextrose-catalase (OADC) enrichment medium (Difco, UK), 25 mg/L amphotericin LOXO-101 molecular weight B, 35 mg/L naladixic acid and 35 mg/L vancomycin. **7H11: Middlebrooks 7H11 (Becton Dickinson, UK) agar supplemented with 2 mg/L Mycobactin J (Allied Monitor, USA), 2.5% glycerol (v/v), 10% OADC (v/v) enrichment medium (Difco, UK), 20% (v/v) new born calf serum, 0.3 g/L asparagine, Mycobacteria Selectatabs (10 mg/L amphotericin B, 200,000 units/L polymixin B, 100 mg/L ticarcillin and 10 mg/L trimethoprim [MAST Laboratories Ltd, UK]). †Liquid Watson Reid: Asparagine 5 g/l, HDAC inhibitor Potassium dihydrogen phosphate 2 g/l, Magnesium suphate 1 g/l, Tri-ammonium citrate 2 g/l, Sodium oxyclozanide chloride 2 g/l, D(+) Glucose 10 g/l, Glycerol 48 ml/l, Ammonium iron (III) citrate brown 0.075 g/l, 1.33mls of Supplement A: 2 g/l Zinc sulphate, 2 g/l Copper sulphate, 1 g/l Cobalt nitrate, 1.33mls of Supplement B; 50 g/l Calcium chloride. ††Liquid Watson Reid ‘A’ Block: as Watson Reid medium but without supplements A and B. DNA extraction DNA was extracted for typing and arrays using a previously described protocol [26]. Briefly, 1×109 cells of cultures grown on liquid Middlebrook 7H9 medium for up to 12 weeks were pelleted, washed once in 1x PBS, then resuspended in 650 μl mycobacterial lysis buffer (0.5 M EDTA –pH 8.0-, 5 M NaCl, 1 M TrisHCl, 10% SDS and 8.6 ml H2O).

Related posts:

1. subtilis strain 168 Results show an increase in the generation t
2. monocytogenes InlA over-expressing strain and ΔinlA strain were c
3. 2%, 79 4%); and during
   
   the second year of life, vaccine e
4. Continued surveillance is required to monitor for strain changes
5. Several regional studies (Reid and Swart, 2004; and frequent tech